ANI Pharmaceuticals, Inc. Announces Receipt of NASDAQ Listing Approval

By: Benzinga
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that it received a letter from NASDAQ informing ANI that its application for initial listing of its common stock on the NASDAQ Global Market has been approved. Accordingly, ANI's common stock will continue to be listed on the NASDAQ Global Market. As previously
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.